Companies › Eli Lilly › Stockholders' equity

Eli Lilly stockholders' equity, 2008–2025

Eli Lilly reported stockholders' equity of $26.5 billion at the end of the fiscal year ended Dec. 31, 2025, up 85.9% from $14.3 billion the year before, according to its Form 10-K.

$26.5Blatest fiscal year (ended Dec. 31, 2025)
+85.9%change from the year before
$26.5Bhighest year shown (2025)
2008: $6.74B ’08 2009: $9.53B 2010: $12.4B ’10 2011: $13.5B 2012: $14.8B ’12 2013: $17.6B 2014: $15.4B ’14 2015: $14.6B 2016: $14.0B ’16 2017: $11.6B 2018: $9.83B ’18 2019: $2.61B 2020: $5.64B ’20 2021: $8.98B 2022: $10.6B ’22 2023: $10.8B 2024: $14.3B ’24 2025: $26.5B ’25

Fiscal years labeled by the year in which they ended. Bars drawn from the table below.

Eli Lilly stockholders' equity by fiscal year

Fiscal year endedStockholders' equityChangeFiling
Dec. 31, 2025 $26.5B +85.9% 10-K (2026) ↗
Dec. 31, 2024 $14.3B +32.5% 10-K (2026) ↗
Dec. 31, 2023 $10.8B +1.1% 10-K (2025) ↗
Dec. 31, 2022 $10.6B +18.6% 10-K (2024) ↗
Dec. 31, 2021 $8.98B +59.2% 10-K (2023) ↗
Dec. 31, 2020 $5.64B +116.4% 10-K (2022) ↗
Dec. 31, 2019 $2.61B −73.5% 10-K (2021) ↗
Dec. 31, 2018 $9.83B −15.2% 10-K (2020) ↗
Dec. 31, 2017 $11.6B −17.2% 10-K (2019) ↗
Dec. 31, 2016 $14.0B −3.9% 10-K (2018) ↗
Dec. 31, 2015 $14.6B −5.2% 10-K (2018) ↗
Dec. 31, 2014 $15.4B −12.8% 10-K (2018) ↗
Dec. 31, 2013 $17.6B +19.4% 10-K (2017) ↗
Dec. 31, 2012 $14.8B +9.0% 10-K (2016) ↗
Dec. 31, 2011 $13.5B +9.0% 10-K (2015) ↗
Dec. 31, 2010 $12.4B +30.4% 10-K (2014) ↗
Dec. 31, 2009 $9.53B +41.4% 10-K (2011) ↗
Dec. 31, 2008 $6.74B — 10-K (2010) ↗

Other Eli Lilly financials

RevenueNet incomeDiluted EPSR&D expenseOperating cash flowDividends per shareDiluted sharesTotal assetsCash and equivalents Quarterly results and next earnings date Eli Lilly company hub

FAQ

Q What was Eli Lilly's stockholders' equity in its latest fiscal year?

A Eli Lilly reported stockholders' equity of $26.5 billion at the end of the fiscal year ended Dec. 31, 2025, up 85.9% from $14.3 billion the year before, according to its Form 10-K.

Q What is Eli Lilly's highest annual stockholders' equity on record here?

A $26.5 billion, in the fiscal year ended Dec. 31, 2025, among the fiscal years 2008–2025 reported in its 10-K XBRL data.

Q Where does this stockholders' equity data come from?

A From Eli Lilly's annual reports on Form 10-K, as tagged in XBRL and published by the SEC (company facts). Total stockholders' equity on the balance sheet at fiscal year-end.

Source: Eli Lilly's annual reports on Form 10-K via SEC XBRL company facts, updated Oct. 15, 2026. Total stockholders' equity on the balance sheet at fiscal year-end. For each year the most recent 10-K that reports it is used, so a figure a company later restated shows the restated value; the filing link shows which report it came from. Change is our arithmetic. Financial data, not investment advice.